Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review
- PMID: 12242114
- DOI: 10.1016/s0167-8140(02)00078-6
Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review
Abstract
Purpose: A systematic review was conducted to develop guidelines for radiotherapy in adult patients with newly diagnosed malignant glioma.
Methods: MEDLINE, CANCERLIT, the Cochrane Library, and relevant conference proceedings were searched to identify randomized trials and meta-analyses.
Results: Pooling of six randomized trials detected a significant survival benefit favouring post-operative radiotherapy compared with no radiotherapy (risk ratio, 0.81; 95% confidence interval, 0.74 to 0.88, P<0.00001). Two randomized trials demonstrated no significant difference in survival rates for whole brain radiation versus more local fields that encompass the enhancing primary plus a 2 cm margin. A randomized trial detected a small improvement in survival with 60 Gy in 30 fractions over 45 Gy in 20 fractions. Radiation dose intensification and radiation sensitizer approaches have not demonstrated superior survival rates compared with conventionally fractionated doses of 50-60 Gy.
Conclusions: Post-operative external beam radiotherapy is recommended as standard therapy for patients with malignant glioma. The high-dose volume should incorporate the enhancing tumour plus a limited margin (e.g. 2 cm) for the planning target volume, and the total dose delivered should be in the range of 50-60 Gy in fraction sizes of 1.8-2.0 Gy. Radiation dose intensification and radiation sensitizer approaches are not recommended as standard care. For patients older than age 70, preliminary data suggest that the same survival benefit can be achieved with less morbidity using a shorter course of radiotherapy. Supportive care alone is a reasonable therapeutic option in patients older than age 70 with a poor performance status.
Similar articles
-
External beam radiation dose escalation for high grade glioma.Cochrane Database Syst Rev. 2020 May 21;5(5):CD011475. doi: 10.1002/14651858.CD011475.pub3. Cochrane Database Syst Rev. 2020. PMID: 32437039 Free PMC article.
-
External beam radiation dose escalation for high grade glioma.Cochrane Database Syst Rev. 2016 Aug 19;(8):CD011475. doi: 10.1002/14651858.CD011475.pub2. Cochrane Database Syst Rev. 2016. Update in: Cochrane Database Syst Rev. 2020 May 21;5:CD011475. doi: 10.1002/14651858.CD011475.pub3 PMID: 27541334 Updated. Review.
-
The American Society for Therapeutic Radiology and Oncology (ASTRO) evidence-based review of the role of radiosurgery for malignant glioma.Int J Radiat Oncol Biol Phys. 2005 Sep 1;63(1):47-55. doi: 10.1016/j.ijrobp.2005.05.024. Int J Radiat Oncol Biol Phys. 2005. PMID: 16111571 Review.
-
The role of radiation therapy in treatment of adults with newly diagnosed glioblastoma multiforme: a systematic review and evidence-based clinical practice guideline update.J Neurooncol. 2020 Nov;150(2):215-267. doi: 10.1007/s11060-020-03612-7. Epub 2020 Nov 19. J Neurooncol. 2020. PMID: 33215344
-
The role of radiotherapy in the management of patients with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline.J Neurooncol. 2015 Dec;125(3):551-83. doi: 10.1007/s11060-015-1948-1. Epub 2015 Nov 3. J Neurooncol. 2015. PMID: 26530266
Cited by
-
Feasibility of intratumoral 165Holmium siloxane delivery to induced U87 glioblastoma in a large animal model, the Yucatan minipig.PLoS One. 2020 Jun 18;15(6):e0234772. doi: 10.1371/journal.pone.0234772. eCollection 2020. PLoS One. 2020. PMID: 32555746 Free PMC article.
-
The evolving roles and controversies of radiotherapy in the treatment of glioblastoma.J Med Radiat Sci. 2016 Jun;63(2):114-23. doi: 10.1002/jmrs.149. Epub 2016 Jan 21. J Med Radiat Sci. 2016. PMID: 27350891 Free PMC article. Review.
-
Phase II trial of radiotherapy after hyperbaric oxygenation with chemotherapy for high-grade gliomas.Br J Cancer. 2006 Oct 9;95(7):862-8. doi: 10.1038/sj.bjc.6603342. Epub 2006 Sep 5. Br J Cancer. 2006. PMID: 16953239 Free PMC article. Clinical Trial.
-
Nimotuzumab as a radiosensitizing agent in the treatment of high grade glioma: challenges and opportunities.Onco Targets Ther. 2013 Jul 24;6:931-42. doi: 10.2147/OTT.S33532. Print 2013. Onco Targets Ther. 2013. PMID: 23926436 Free PMC article.
-
RIG-I-like receptor LGP2 protects tumor cells from ionizing radiation.Proc Natl Acad Sci U S A. 2014 Jan 28;111(4):E484-91. doi: 10.1073/pnas.1323253111. Epub 2014 Jan 13. Proc Natl Acad Sci U S A. 2014. PMID: 24434553 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical